Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HEmodynamic Assessment of Optimal Left Heart Lead Placement for Heart Failure Enabled by Magnetic Navigation

NCT00370526 is registered in ClinicalTrials.gov with Stereotaxis as lead sponsor.

NCT NCT00370526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00370526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HEmodynamic Assessment of Optimal Left Heart Lead Placement for Heart Failure Enabled by Magnetic Navigation
Lead sponsor
Stereotaxis
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2007
Completion date
December 31, 2007
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive